Just a matter of when, not if.
Massive uptake already in Australia, being the most used technology in Australian aged care facilities and represented in every major town across the country. Huge growth in the UK and NZ on the way. Objective and able to be used by all, with or without dementia, and even those too young to speak. No one can provide any evidence to dispute these facts.
- Forums
- ASX - By Stock
- PCK
- PainChek General Discussion
PainChek General Discussion, page-19859
Featured News
Add PCK (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.8¢ |
Change
-0.003(9.68%) |
Mkt cap ! $45.84M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.8¢ | $64.49K | 2.298M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 38188 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 38188 | 0.028 |
4 | 1287037 | 0.027 |
4 | 1040000 | 0.026 |
4 | 1159601 | 0.025 |
1 | 41252 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 65000 | 1 |
0.031 | 18000 | 1 |
0.032 | 89187 | 1 |
0.033 | 100000 | 1 |
0.034 | 108791 | 1 |
Last trade - 15.14pm 12/11/2024 (20 minute delay) ? |
Featured News
PCK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online